This message was sent to ##Email##
|
|
|
|
|
AST
Visit the AST Member Spotlight page to read about Nissreen Elfadawy's journey as an international medical grad.
Interested in being featured in the AST Member Spotlight? Please contact rpaulin@myast.org for more information.
AST
We hope you had the opportunity to make new connections at ATC 2019! Did you know that AST members have access to a member directory? Check out this networking opportunity on the COP Hub.
READ MORE
AST
Join the American Society of Transplantation (AST), the European Society for Organ Transplantation (ESOT), and The Transplantation Society (TTS) for the International Transplantation Science (ITS) meeting in Clearwater Beacher, Florida. This meeting will provide in-depth, cutting-edge basic science with talks by leading experts in select topics in transplantation and immunology.
Early bird registration is now open. Don't miss the opportunity to connect with your colleagues at this intimate meeting.
READ MORE
| . |
SPONSORED VIDEO |
Advertisement
|
 |
|
Promoted by
Veloxis Pharaceuticals
Watch kidney transplant patients talk about their diagnoses and the importance of communication with their doctors and transplant teams. For these patients, switching therapies made sense.
See the video
|
|
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career – from basic trainee lessons to webinars on specialized topics. Learn More
AST
Transplant professionals have increasing demands on their time. Finding time in one's day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
Advertisement
Veloxis Pharmaceuticals
Explore this phase 3 randomized, double-blind, double-dummy, multicenter, multinational, non-inferiority trial published in the American Journal of Transplantation. The study examined treatment failures defined as BPAR, graft failure, death, and delayed graft function at 3 months and 12 months.
Explore data
|
AST
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
|
The Enhanced LSA assay demonstrates a lower
false positive rate1
—increasing your ability to find
acceptable donors and providing new beginnings
for more transplant patients. With added coverage
and specificity, our test is designed for you, to
improve operational efficiencies and workflow.
Learn more
|
|
|
|
|
| Upcoming Education Events
|
    |
AST
Billing for Living Kidney Donor Care: Balancing Cost Recovery, Regulatory Compliance, and Minimized Donor Burden
June 18, 2019 | 2 pm ET | Online Activity
For more information, click here.
AJT
Cohosts Josh Levitsky, MD, and Roslyn Mannon, MD, discuss the latest issues of the American Journal of Transplantation, summarizing Editors’ Picks by highlighting the key messages, broader impact, and take-home points of each article. The views are their own and do not necessarily reflect those of the journal or the Societies that support it. Available on iTunes, Google Play, Stitcher, and Podbean.
READ MORE
AST
The American Society of Transplantation (AST) announced the recipients of its 2019 Achievement Awards and grant recipients at the American Transplant Congress (ATC) meeting in Boston, MA. The recipients were awarded for their achievements and contributions to the AST and the field of transplantation
READ MORE
Journal of Hepatology
Although there is increasing interest in its use, definitive evidence demonstrating a benefit for postmortem normothermic regional perfusion (NRP) in controlled donation after circulatory death (cDCD) liver transplantation is lacking. The aim of this study was to compare results of cDCD liver transplants performed with postmortem NRP vs. super-rapid recovery (SRR), the current standard for cDCD.
READ MORE
Journal of Hepatology
A continuing discrepancy between organ availability and demand has forced utilization of extended criteria donor (ECD) livers, including donation after circulatory death, elderly or steatotic grafts, which are at increased risk of failure after transplantation. Especially for ECD grafts, dynamic preservation using ex situ machine perfusion (MP) allows reconditioning and viability assessment of livers prior to transplantation, rather than standard static cold storage (SCS) alone.
READ MORE
|
|
JAMA Network
In this cohort study of 42,558 patients, racial disparities were reduced for most patients after implementation of the Kidney Allocation System. However, there continue to be significant racial/ethnic differences in transplant probability for patients who are highly sensitized.
READ MORE
JAMA Network
Approximately 40% of patients with end stage renal disease (ESRD) have ischemic heart disease.1 Given this high prevalence, many renal transplant centers assess patients for ischemic heart disease in the pretransplant evaluation. Once accepted as a transplant candidate and placed on the waiting list, there is little guidance regarding subsequent stress testing in asymptomatic individuals.
READ MORE
Advertisement
 |
|
CareDx announces KidneyCare. KidneyCare combines clinically validated AlloSure testing with AlloMap Kidney and iBox to deliver personalized and prognostic solutions for transplant patients. MORE
|
|
AJT via Wiley Online Library
TRANSFORM was a 24‐month, prospective, open‐label trial in 2037 de novo renal transplant recipients (RTxRs) randomized (1:1) within 24 hours of transplantation to receive everolimus (EVR) with reduced‐exposure calcineurin inhibitor (EVR+rCNI) or mycophenolate with standard‐exposure CNI (MPA+sCNI).
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
